In PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survival
Authors:
- Daniel GotthardtDGDaniel Gotthardt
- Petra Kloeters-PlachkyPKPetra Kloeters-Plachky
- Daniel RostDRDaniel Rost
- Hasan KulaksizHKHasan Kulaksiz
- Adolf StiehlASAdolf Stiehl
- 1 August 2010
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 53 (2) , 313-317
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis #Hepatology, 2009
- The incidence of cholangiocarcinoma in primary sclerosing cholangitis after long-time treatment with ursodeoxycholic acidEuropean Journal of Gastroenterology & Hepatology, 2007
- Biliary candida infections in primary sclerosing cholangitisJournal of Hepatology, 2006
- Primary Sclerosing Cholangitis: The Role of Endoscopic TherapySeminars in Liver Disease, 2006
- Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitisHepatology, 2004
- Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted liversJournal of Hepatology, 1998
- Ursodiol for Primary Sclerosing CholangitisNew England Journal of Medicine, 1997
- Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitisJournal of Hepatology, 1997
- Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study periodJournal of Hepatology, 1994
- Rank Tests and a One-Sample Logrank Test for Comparing Observed Survival Data to a Standard Population1981